Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma
10.1038/s41408-021-00421-7
Saved in:
Main Authors: | Jia, Yunlu, Zhou, Jianbiao, Tan, Tze King, Chung, Tae-Hoon, Wong, Regina Wan Ju, Chooi, Jing-Yuan, Lim, Julia Sze Lynn, Sanda, Takaomi, Ooi, Melissa, De Mel, Sanjay, Soekojo, Cinnie, Chen, Yongxia, Zhang, Enfan, Cai, Zhen, Shen, Peng, Ruan, Jian, Chng, Wee-Joo |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Language: | English |
Published: |
SPRINGER NATURE
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/205901 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Immunotherapy in Multiple Myeloma
by: Soekojo, Cinnie Yentia, et al.
Published: (2022) -
Genomic characterization of functional high-risk multiple myeloma patients
by: Soekojo, Cinnie Yentia, et al.
Published: (2022) -
Daratumumab-based induction therapy for multiple myeloma: A systematic review and meta-analysis
by: Chong, Lip Leong, et al.
Published: (2021) -
Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis
by: Teoh, Phaik Ju, et al.
Published: (2019) -
Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network
by: Soekojo, Cinnie Yentia, et al.
Published: (2022)